Investors / United States / Mesa Verde Venture Partners
Mesa Verde Venture Partners
Venture capital · San Diego, CA, United States · North America
Mesa Verde Venture Partners is an early-stage life sciences venture capital firm that partners with entrepreneurs to build companies. It has over 20 years of experience and more than 20 life sciences investments, and is based in San Diego, California.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiomedicalpharmaceuticalsmedical devicesdiagnosticsdigital health
Your fit with Mesa Verde Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMesa Verde Venture Partners lists 15 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 90% of its companies are based in United States. It invests most often alongside Global Source Ventures, Aisling Capital and NEA.
Counts come from funding rounds that name Mesa Verde Venture Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Mesa Verde Venture Partners' whole history. Rounds on record name 1 company; its own site lists 15. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 39th | 15 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Global Source Ventures | 3 |
| Aisling Capital | 2 |
| NEA | 2 |
| Pappas Capital | 2 |
| Sanderling Ventures | 2 |
| ARCH Venture Partners | 1 |
| Abingworth | 1 |
| Advent Life Sciences | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1493%
- No longer answers00%
- Points to another company17%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Global Source Ventures
Compare Mesa Verde Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Mesa Verde Venture Partners| Date | Company | Stage |
|---|---|---|
| 3 Apr 2026 | Seed |
Round details for Mesa Verde Venture Partners
Amounts, full round histories and every co-investor in Mesa Verde Venture Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
15 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acurion develops and provides a technology called OncoGaze that delivers genomic insights to help oncologists make precision therapy decisions for cancer patients | Healthcare & Biotech | Apr 2026Seed | Funding round | |
| Alastin develops and sells skincare products | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| CalciMedica is a biopharmaceutical company developing investigational treatments for pulmonary hypertension and acute pancreatitis | Healthcare & Biotech | Portfolio page | ||
| ElysiumRx engineers therapeutic profiles to preserve efficacy while improving safety, usability, and real-world performance of medicines. | Healthcare & Biotech | Portfolio page | ||
| Equillium develops new products for severe autoimmune and inflammatory disorders | Healthcare & Biotech | Portfolio page | ||
| Exagen provides physicians with advanced testing for accurate and timely diagnosis, prognosis and monitoring of autoimmune conditions. | Healthcare & Biotech | Portfolio page | ||
| Glycomine is developing replacement therapies for rare genetic diseases | Healthcare & Biotech | Portfolio page | ||
| Immusoft engineers B cells as biofactories for therapeutic protein delivery | Healthcare & Biotech | Portfolio page | ||
| Independa provides health and wellness services on various screens, including TV, tablet, computer, or phone | Healthcare & Biotech | Portfolio page | ||
| The company provides genetic testing and counseling services | Healthcare & Biotech | Portfolio page | ||
| Mirum Pharmaceuticals focuses on developing and delivering treatments for rare diseases | Healthcare & Biotech | Portfolio page | ||
| The company is a clinical-stage oncology company | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| The company develops and commercializes products that treat central nervous system diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mesaverdevp.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 3 Apr 2026
- Companies checked
- 15
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Mesa Verde Venture Partners' profile as data
Pull Mesa Verde Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mesaverdevp.com
# also
GET /v1/firms/mesaverdevp.com/portfolio
GET /v1/firms/mesaverdevp.com/coinvestors
GET /v1/firms/mesaverdevp.com/news